✦ LIBER ✦

Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience

✍ Scribed by Wallace V. Epstein

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 679 KB
Volume: 39
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780391102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind, placebo-controlled multice

Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-cd4 antibody, cm-t412, in rheumatoid arthritis patients receiving concomitant methotrexate

✍ Larry W. Moreland; Parks W. Pratt; Maureen D. Mayes; Arnold Postlethwaite; Micha 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Percentage of anti-CD4 monoclonal antibo

Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens

✍ Ernest H. S. Choy; Costantino Pitzalis; Alberto Cauli; J. A. Bijl; Allen Schantz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Adalimumab, a fully human anti–tumor nec

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

✍ Michael E. Weinblatt; Edward C. Keystone; Daniel E. Furst; Larry W. Moreland; Mi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Treatment with monoclonal anti–tumor nec

Treatment with monoclonal anti–tumor necrosis factor α antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis

✍ Madelon M. Maurice; Wiebo L. Van Der Graaff; Angela Leow; Ferdinand C. Breedveld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

Morbidity not increased in rheumatoid ar

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: Comment on the article by Isaacs et al

✍ Yamini Menon; Ranju Singh; Raquel Cuchacovich; Luis R. Espinoza 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Ocrelizumab, a humanized anti-CD20 monoc

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

✍ Mark C. Genovese; Jeffrey L. Kaine; Mitchell B. Lowenstein; José Del Giudice; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB